According to the note, the paper was “editorially rejected following peer review and consultation with the Editorial Board,” but ended up going through the production process anyway.
When we contacted the authors, they filled us in with more details.
Two out of the three authors of a PNAS paper on mutations underlying lung diseases are pulling it after failing to reproduce key findings.
The paper, published in 2012, investigated how mutations in lung surfactant genes induce molecular changes that lead to lung pulmonary fibrosis and lung cancer might work. But follow-up work revealed problems. In the retraction note, last author Christine Kim Garcia and second author Christoper Cano, both at the University of Texas Southwestern Medical Center, write:
Current members of the C.K.G. laboratory are unable to reproduce key findings reported in the paper.
Dutch social psychologist and well-known fraudster Diederik Stapel is up to 55 retractions. He remains secure in his spot at #4 on our leaderboard.
The “fraudulent” Social Cognition article found, according to its abstract, that the more positively you perceive yourself, the less you need to compare yourself to other people. Conversely, negative thoughts were linked to more comparison to others. As an article in the New York Timespoints out, where Stapel’s faulty studies often succeeded is in telling us what we want to believe about the world.
According to the Directory of Open Access Journals (DOAJ), the International Archives of Medicine was removed from the list of member journals August 20, due to “suspected editorial misconduct by publisher.”
A former graduate student at the University of California, San Francisco “knowingly falsified and/or fabricated” data in two published papers, according to the Office of Research Integrity.
According to a case summary published this morning, Peter Littlefield was working on his PhD, studying the ways that cells respond to external signals, when he published the two problematic papers. He is the first author on the papers; Natalia Jura, whose lab he worked in, is the last on both.
The report’s findings are based on, among other sources, “the respondent’s admission.”
A paper on the evolution and development of urochordata — also known as sea squirts — was published in an under-developed form: Due to the publishers’ “error,” a “preliminary draft” of the article was published online in Developmental Dynamics last year.
The draft has been retracted; we can no longer find it on the site at all. The final copy of the paper has been posted in its place.
Here’s the retraction note in full for “Development, Metamorphosis, Morphology and Diversity: Evolution of Chordates muscles and the Origin of Vertebrates”:
Community blog PLOS Biologue has pulled a post by journalists Charles Seife and Paul Thacker that argued in favor of public scrutiny of scientists’ behavior (including emails), following heavy criticism, including from a group and scientist mentioned in the post.
Their reasoning: The post was “not consistent with at least the spirit and intent of our community guidelines.”
It may not be much of a surprise that narcissistic CEOs of pharmaceutical companies will make bold choices, such as adopting radically new technology. That idea remains true, despite a lengthy correction to a paper that supports it.
A former graduate student at Wake Forest School of Medicine “presented falsified and/or fabricated data” in a government-funded drug study, according to findings released by the U.S. Office of Research Integrity earlier today.
The report was released in the wake of an investigation conducted by the university and the ORI. Investigators found that although Brandi Blaylock recorded responses of a dozen laboratory monkeys after giving them anti-abuse drugs, she hadn’t given them the compounds “per protocol.”
Blaylock then presented the data at “two poster presentations, several laboratory meetings, and progress reports.”
Some of her research was supported by a grant from the National Institute of Drug Abuse, “Dopamine D2 Receptors In Primate Models of Cocaine Abuse,” which examined the effects of novel dopamine D3 receptor compounds on drug addiction on monkeys.